Sanofi’s Enjaymo, once a jewel in its Bioverativ buyout, finally wins its FDA nod for a rare blood disorder
Sanofi’s Enjaymo, once a jewel in its Bioverativ buyout, finally [...]
Regeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it
Regeneron projects no near-term sales of its blockbuster COVID-19 antibody [...]
The hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes
The hits keep coming: Biogen’s Aduhelm marketing, approval under fire [...]
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid [...]
UPDATED: Sanofi’s flu shots took a back seat to COVID-19 boosters late last year, and major job cuts still loom
UPDATED: Sanofi’s flu shots took a back seat to COVID-19 [...]
Sanofi’s Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter
Sanofi’s Dupixent rolls on, but US flu shots took backseat [...]
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending crown
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending [...]
Fierce Pharma Asia—AstraZeneca China’s fraud investigation; Women promoted at Takeda; Samsung buy of Biogen’s stake in biosimilar JV
Fierce Pharma Asia—AstraZeneca China’s fraud investigation; Women promoted at Takeda; [...]
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too
Sanofi launches new corporate brand and logo, and that goes [...]
Roche revs up new launches—and a slew of data readouts—as it emerges from the biosim trough
Roche revs up new launches—and a slew of data readouts—as [...]